GC Green Cross MS Localizes Korea's First Powdered Hemodialysis Agent

by Choi Taewon

Published 16 Oct.2025 09:33(KST)

Advantages in Logistics and Cost

GC Green Cross MS, a company specializing in in vitro diagnostics and hemodialysis solution manufacturing, announced on October 16 that it has developed the first powdered hemodialysis agent in Korea and has begun full-scale production and sales.

Powdered Hemodialysis Agent 'HDVisan'. GC Green Cross MS

Hemodialysis treatment uses both an acidic "A solution" and an alkaline "B solution" to maintain the pH level of the blood. The newly approved product is a powdered version of the B solution, designed to address the shortcomings of the conventional liquid formulation, and is the first of its kind to be approved in Korea. With this approval, GC Green Cross MS now offers a complete lineup of A solution, B solution, and powdered B solution for dialysis.

The powdered product is smaller and lighter than existing liquid formulations, which helps reduce logistics and transportation costs, providing a significant advantage in terms of cost. In addition, unlike the imported sealed products currently sold in the domestic market, this product features a container and lid that can be separated, making it easier to dispose of any remaining contents and thereby enhancing convenience for medical institutions.

Since 2022, the company has established a dedicated production line for powdered hemodialysis agents at its Eumseong HD plant in North Chungcheong Province, enabling mass production. Having recently obtained manufacturing approval, GC Green Cross MS has signed supply contracts with major domestic companies and has begun sales.

A representative from GC Green Cross MS stated, "Until now, all powdered hemodialysis agents sold domestically have been entirely dependent on imports. With this launch, we expect to achieve import substitution and ensure a stable supply of products in Korea, which will significantly improve the treatment environment for domestic hemodialysis patients. We are also actively pursuing direct exports."